We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 522

Sequestration impact on FDA uncertain

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 7 2013

Speaking during the Generic Pharmaceutical Association's annual conference in February 2013, Food and Drug Administration (FDA) Commissioner Margaret

USDA proposes adding 14 product categories to its BioPreferred list

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • December 16 2010

The U.S. Department of Agriculture (USDA) has issued a proposed rule that would add 14 biobased product categories to its list of preferred items for federal procurement under the agency’s BioPreferred Program

USPTO plan to fast-track humanitarian patent re-examination unsound?

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • December 16 2010

In response to a U.S. Patent and Trademark Office (USPTO) proposal to expedite the re-examination of patents for technologies addressing humanitarian needs, three intellectual property (IP) organizations have apparently filed comments in opposition

USPTO seeks comments on rules for ex parte patent appeals

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • December 16 2010

The U.S. Patent and Trademark Office (USPTO) has issued a notice of proposed rulemaking that seeks public comments on proposed new revisions to current procedures governing practice before the Board of Patent Appeals and Interferences

EPA approves biofuel additive

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • December 16 2010

Gevo Inc., a Colorado-based renewable chemicals and advanced biofuels company, recently announced that the Environmental Protection Agency (EPA) has cleared its isobutanol for use as a fuel additive

Appeals Court considers federal funding of stem cell research

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • December 16 2010

A D.C. Circuit Court of Appeals panel recently heard argument on whether new National Institutes of Health (NIH) guidelines pertaining to federal funding of embryonic stem-cell research violate a law that places certain restrictions on such research

New biotech initiative in San Francisco

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • December 16 2010

San Francisco has reportedly started a new initiative to expand biotech and life-sciences startups in areas that include Mission Bay, Pier 70 and the former Hunters Point Naval Shipyard

News bytes

  • Shook Hardy & Bacon LLP
  • -
  • European Union, USA
  • -
  • December 16 2010

The European Medicines Agency (EMA) adopts two draft guidelines as part of the regulatory approval process for certain biosimilar medicinal products

Israeli biotechnology startups seek partnerships in Ohio

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • December 16 2010

Israeli biotechnology companies are reportedly heading to Ohio because of state incentives and a venture capital fund focused on investing in Israel

Avalon Ventures closes ninth and largest fund

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • January 13 2011

Avalon Ventures, located near San Diego, California, has reportedly closed capital commitments of $200 million for its ninth and largest fund, Avalon Ventures IX, LP

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy